Bausch Health Companies BHC Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

HRO

HarrowHROW

$4.36M—

Henry ScheinHSIC

$64M-42.9%

AbbottABT

$1M-97.4%

ANI PharmaceuticalsANIP

$9.25M-46.9%

Bausch + LombBLCO

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

See full

Market cap$1.86B-15.9%

Profitability

See full

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch Health Companies's contingent consideration liability (non-current)?: Bausch Health Companies (BHC) reported contingent consideration liability (non-current) of $213M in Q1 2026.
How has Bausch Health Companies's contingent consideration liability (non-current) changed year-over-year?: Bausch Health Companies's contingent consideration liability (non-current) decreased by 24.5% year-over-year, from $282M to $213M.